SCHEMBL20339293

SCHEMBL20339293

CCc1ncncc1C(=O)Nc1cccc(Cl)c1NC1CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 3/20 0.42
MAPK14 Q16539 3/20 0.42
GAA P10253 1/20 0.39
LMNA P02545 1/20 0.37
PDE10A Q9Y233 1/20 0.36
CHRNA7 P36544 1/20 0.36
IRAK4 Q9NWZ3 2/20 0.35
RXFP1 Q9HBX9 1/20 0.35
PDCD1 Q15116 1/20 0.35
CD274 Q9NZQ7 1/20 0.35
CDK7 P50613 1/20 0.35
CDK9 P50750 1/20 0.35
MCL1 Q07820 1/20 0.35
AXL P30530 1/20 0.35
FLT3 P36888 1/20 0.35
TYRO3 Q06418 1/20 0.35
MERTK Q12866 1/20 0.35
GAS6 Q14393 1/20 0.35
KDR P35968 1/20 0.35
MAPK13 O15264 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20337692 0.82 S1PR1 (0.38) LMNAPDE10AIRAK4AXLFLT3
SCHEMBL20337714 0.80 LMNA (0.46) GAALMNAIRAK4
SCHEMBL20337737 0.78 IRAK4 (0.42) PDE10AIRAK4
SCHEMBL20337658 0.76 MRGPRX1 (0.41) LMNAPDE10AIRAK4AXLTYRO3
SCHEMBL20337768 0.74 IRAK4 (0.44) MAPK14PDE10AIRAK4JAK3
SCHEMBL20337738 0.69 ALDH1A1 (0.42) MAPK14PDE10AIRAK4AXLFLT3
SCHEMBL12791635 0.68 SMN1; SMN2 (0.51) LCKMAPK14
SCHEMBL20337697 0.67 MAPK14 (0.44) MAPK14PDE10AIRAK4JAK3
SCHEMBL31361672 0.66 PDE4A (0.43) LCKMAPK14GAALMNAIRAK4
SCHEMBL20345757 0.66 ABL1 (0.42) IRAK4ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3562306-A2 METALLOENZYME INHIBITOR COMPOUNDS Selenity Therapeutics (Bermuda), Ltd. (BM) 2019-11-06 EP disclosed
WO-2018125799-A2 METALLOENZYME INHIBITOR COMPOUNDS VIAMET PHARMACEUTICALS (BERMUDA), LTD. (BM) 2018-07-05 WO disclosed